Outlook Shares Jump Following FDA Appeal Decision For LYTENAVA - Outlook Therapeutics (NASDAQ:OTLK)

Outlook Therapeutics Inc. shares are trading higher Tuesday after the FDA granted its appeal in the ONS-5010 dispute resolution process.